Literature DB >> 8757949

The nature of cryptic epitopes within the self-antigen myelin basic protein.

P J Fairchild1, H Pope, D C Wraith.   

Abstract

Mechanisms that allow potentially autoreactive T cells to escape central tolerance and persist in the peripheral lymphoid organs of healthy individuals are poorly defined. It has been proposed that such cells are specific for epitopes which normally are not well presented to the immune system or, in other words, are cryptic. We have used synthetic peptides to define potential T cell epitopes within the N-terminal portion of myelin basic protein (MBP). These were defined in terms of their relative affinity for the MHC-restriction element I-Au and their ability to activate T cells in mice of the H-2(u) haplotype. Three epitopes were identified, one of which corresponded to the known dominant N-terminal epitope (Ac1-9). The other two epitopes (9-20 and 5-20) bound to their MHC-restriction element with relatively high affinity but were cryptic, as defined by the poor response to these epitopes following immunization with intact MBP. Even the longer of these two epitopes did not induce autoimmune encephalomyelitis in H-2(u) mice. These results demonstrate that antigen processing can control both the induction of and effector function of autoreactive T cells, and is therefore a principal mechanism involved in limiting the autoreactive T cell repertoire.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757949     DOI: 10.1093/intimm/8.7.1035

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Autoreactive T cells can be protected from tolerance induction through competition by flanking determinants for access to class II MHC.

Authors:  Emanual Maverakis; Jonathan Beech; David B Stevens; Akio Ametani; Laurent Brossay; Peter van den Elzen; Richard Mendoza; Quoc Thai; Luis H Macias; Doug Ethell; Celia W Campagnoni; Anthony T Campagnoni; Alessandro Sette; Eli E Sercarz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-21       Impact factor: 11.205

2.  Increasing the frequency of T-cell precursors specific for a cryptic epitope of hen-egg lysozyme converts it to an immunodominant epitope.

Authors:  T H Thatcher; D P O'Brien; S Altuwaijri; R K Barth
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

Review 3.  Immune tolerance to myelin proteins.

Authors:  Audrey Seamons; Antoine Perchellet; Joan Goverman
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 4.  Unconventional recognition of peptides by T cells and the implications for autoimmunity.

Authors:  James F Mohan; Emil R Unanue
Journal:  Nat Rev Immunol       Date:  2012-09-07       Impact factor: 53.106

5.  Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.

Authors:  Andrew J Bordner
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

6.  Negative selection during the peripheral immune response to antigen.

Authors:  S M Anderton; C G Radu; P A Lowrey; E S Ward; D C Wraith
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

7.  Prediction of the binding affinities of peptides to class II MHC using a regularized thermodynamic model.

Authors:  Andrew J Bordner; Hans D Mittelmann
Journal:  BMC Bioinformatics       Date:  2010-01-20       Impact factor: 3.169

8.  Flanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323-339.

Authors:  Benjamin M Roy; Dmitriy V Zhukov; Jennifer A Maynard
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

9.  Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal.

Authors:  S Ceman; S Wu; T S Jardetzky; A J Sant
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

10.  Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity.

Authors:  Audrey Seamons; Jennifer Sutton; Dina Bai; Emily Baird; Nena Bonn; Björn F C Kafsack; Jeffrey Shabanowitz; Donald F Hunt; Craig Beeson; Joan Goverman
Journal:  J Exp Med       Date:  2003-05-19       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.